Events
![](/upload/resize_cache/iblock/593/386_220_2/593b2b2d47d186c50792461b50d3b0c0.jpg)
Press Center
![](/upload/resize_cache/iblock/31d/140_80_2/31dfbdd6866855f08968a3f638b26ca0.jpg)
22.03.2016
Petrovax Pharm is launching production of a state-of-the-art flu vaccine using virus antigens produced in Russia. The Ministry of Health of the Russian Federation has given the green light to start production.
More
Topics Petrovax Pharm